Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
13-NOV-2024 | 5,500 | 5,637.6 | 5,361.05 | 5,571.2 | 96,232 | 3,40,94,30,294.75 | 1,83,006 |
14-NOV-2024 | 5,566.05 | 5,665.95 | 5,491.55 | 5,524.95 | 70,332 | 1,71,64,54,710.1 | 1,62,670 |
18-NOV-2024 | 5,550 | 5,608.6 | 5,492.5 | 5,515.15 | 44,232 | 1,47,84,79,746.55 | 1,69,163 |
19-NOV-2024 | 5,490 | 5,599.8 | 5,463 | 5,529.8 | 55,853 | 1,57,77,08,645.6 | 1,77,213 |
21-NOV-2024 | 5,571 | 5,665 | 5,532.05 | 5,604.75 | 62,440 | 2,88,11,33,875.25 | 3,18,497 |
22-NOV-2024 | 5,605.15 | 5,622.8 | 5,511.5 | 5,583.35 | 25,369 | 60,38,23,017.15 | 48,456 |
25-NOV-2024 | 5,699 | 5,718.5 | 5,374.2 | 5,478.3 | 1,57,569 | 33,30,28,43,037.9 | 38,96,271 |
26-NOV-2024 | 5,437.1 | 5,538.85 | 5,433 | 5,484.4 | 37,758 | 1,09,05,33,872.05 | 1,06,874 |
27-NOV-2024 | 5,497.25 | 5,528.95 | 5,401.35 | 5,449.85 | 25,962 | 89,07,69,747.85 | 97,854 |
28-NOV-2024 | 5,459 | 5,492.5 | 5,418.85 | 5,457.15 | 27,309 | 88,36,31,716.8 | 96,013 |
29-NOV-2024 | 5,472 | 5,650 | 5,457.15 | 5,642.45 | 42,940 | 1,62,31,61,008.9 | 1,60,105 |
02-DEC-2024 | 5,658 | 5,751 | 5,650 | 5,692.75 | 25,844 | 70,61,24,354.55 | 54,681 |
03-DEC-2024 | 5,708.8 | 5,722.7 | 5,621.45 | 5,637.35 | 32,800 | 80,15,77,933.1 | 95,684 |
04-DEC-2024 | 5,647.8 | 5,716.2 | 5,632.8 | 5,672.7 | 46,339 | 1,31,60,99,461.25 | 1,64,630 |
05-DEC-2024 | 5,629.55 | 5,681.85 | 5,580.05 | 5,643.95 | 38,180 | 91,86,84,546.05 | 86,197 |
06-DEC-2024 | 5,631 | 5,649.85 | 5,493.05 | 5,505.4 | 28,768 | 1,12,16,11,729.6 | 1,26,022 |
09-DEC-2024 | 5,532.95 | 5,700 | 5,461.1 | 5,484.6 | 21,185 | 62,48,48,258.9 | 55,969 |
10-DEC-2024 | 5,495.1 | 5,508.75 | 5,433 | 5,459.45 | 25,147 | 74,38,29,087.5 | 94,410 |
11-DEC-2024 | 5,474 | 5,516.8 | 5,425.05 | 5,489.95 | 18,039 | 43,62,58,247.2 | 47,585 |
12-DEC-2024 | 5,529.45 | 5,535 | 5,405.5 | 5,435.25 | 27,087 | 71,31,36,215.15 | 83,613 |
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
